31-03-2025
Hearing Loss Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hearing Loss pipeline constitutes 32+ key companies continuously working towards developing 35+ Hearing Loss treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
' Hearing Loss Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hearing Loss Market.
The Hearing Loss Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Hearing Loss Pipeline Report:
Companies across the globe are diligently working toward developing novel Hearing Loss treatment therapies with a considerable amount of success over the years.
Hearing Loss companies working in the treatment market are Acousia Therapeutics, Decibel Therapeutics, Suzhou Pharmaceutical Technology Co.,Ltd, AudioCure Pharma GmbH, Sensorion, and others, are developing therapies for the Hearing Loss treatment
Emerging Hearing Loss therapies in the different phases of clinical trials are- ACOU085, Cochlear Hair Cell Regeneration, HY01, AC102, SENS-401, and others are expected to have a significant impact on the Hearing Loss market in the coming years.
In February 2025, Sound Pharmaceuticals is excited to share that it will deliver four presentations at the upcoming Association for Research in Otolaryngology MidWinter Meeting. One of the key presentations, titled "The Development of SPI-1005 for the Treatment of Hearing Loss and Tinnitus," will be featured at the Pharmaceutical Interventions for Hearing Loss (PIHL) Satellite Symposium. Organized by the Defense Health Agency (DHA) Hearing Center of Excellence (HCE) committee, this symposium will offer an in-depth review of investigational treatments aimed at preventing hearing loss and promoting hearing restoration.
In January 2025, US-based dermatology biopharma Eirion Therapeutics reported positive findings from its first-in-human, double-blind, placebo-controlled study of its topical treatment for age-related hair loss, demonstrating a six-fold increase in hair count over placebo. ET-02, the company's most advanced therapy for androgenic alopecia, was evaluated in a trial involving 24 male patients across three US sites, successfully meeting its primary safety and tolerability endpoints. Additionally, Eirion Therapeutics is advancing a preclinical oral version of ET-02, further expanding its pipeline for hair loss treatments.
In August 2024, Pelage Pharmaceuticals, a clinical-stage company specializing in regenerative medicine for hair loss, commenced its Phase 2a clinical trial for PP405, a novel topical small molecule aimed at treating androgenetic alopecia (pattern baldness). The first patients have been dosed, and the study will evaluate the drug's safety and effectiveness. The trial plans to enroll 60 men and women, with PP405 designed to activate dormant hair follicle stem cells, promoting hair growth
Hearing Loss Overview
Hearing Loss (SNHL) occurs due to damage to inner ear structures or the auditory nerve. It accounts for over 90 percent of hearing impairment in adults. Typical causes of SNHL include prolonged exposure to loud noises, genetic predisposition, or the natural aging process.
Emerging Hearing Loss Drugs Under Different Phases of Clinical Development Include:
ACOU085: Acousia Therapeutics
Cochlear Hair Cell Regeneration: Decibel Therapeutics
HY01: Suzhou Pharmaceutical Technology Co.,Ltd
AC102: AudioCure Pharma GmbH
SENS-401: Sensorion
Hearing Loss Route of Administration
Hearing Loss pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
Intra-articular
Intraocular
Intrathecal
Intravenous
Ophthalmic
Oral
Parenteral
Subcutaneous
Topical
Transdermal
Hearing Loss Molecule Type
Hearing Loss Products have been categorized under various Molecule types, such as
Products have been categorized under various Molecule types such as
Oligonucleotide
Peptide
Small molecule
Hearing Loss Pipeline Therapeutics Assessment
Hearing Loss Assessment by Product Type
Hearing Loss By Stage and Product Type
Hearing Loss Assessment by Route of Administration
Hearing Loss By Stage and Route of Administration
Hearing Loss Assessment by Molecule Type
Hearing Loss by Stage and Molecule Type
DelveInsight's Hearing Loss Report covers around 35+ products under different phases of clinical development like
Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration
Some of the key companies in the Hearing Loss Therapeutics Market include:
Key companies developing therapies for Hearing Loss are - Sensorion, Fennec Pharmaceuticals, Sound Pharmaceuticals, Decibel Therapeutics, Akouos, and others.
Hearing Loss Pipeline Analysis:
The Hearing Loss pipeline report provides insights into
The report provides detailed insights about companies that are developing therapies for the treatment of Hearing Loss with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Hearing Loss Treatment.
Hearing Loss key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Hearing Loss Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Hearing Loss market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Hearing Loss drugs and therapies
Hearing Loss Pipeline Market Drivers
Rise in the Incidence of Hearing Loss, rising Awareness and Initiatives about Hearing loss are some of the important factors that are fueling the Hearing Loss Market.
Hearing Loss Pipeline Market Barriers
However, high Cost of treatment, presence of Substitute Products and other factors are creating obstacles in the Hearing Loss Market growth.
Scope of Hearing Loss Pipeline Drug Insight
Table of Contents
1. Hearing Loss Report Introduction
2. Hearing Loss Executive Summary
3. Hearing Loss Overview
4. Hearing Loss- Analytical Perspective In-depth Commercial Assessment
5. Hearing Loss Pipeline Therapeutics
6. Hearing Loss Late Stage Products (Phase II/III)
7. Hearing Loss Mid Stage Products (Phase II)
8. Hearing Loss Early Stage Products (Phase I)
9. Hearing Loss Preclinical Stage Products
10. Hearing Loss Therapeutics Assessment
11. Hearing Loss Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Hearing Loss Key Companies
14. Hearing Loss Key Products
15. Hearing Loss Unmet Needs
16 . Hearing Loss Market Drivers and Barriers
17. Hearing Loss Future Perspectives and Conclusion
18. Hearing Loss Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website:
